Medical device company AngioDynamics Inc (NASDAQ:ANGO) said on Tuesday that Michael C. Greiner plans to step down as its executive vice president and chief financial officer (CFO).
In conjunction with the change, the company's senior vice president and general counsel Stephen A. Trowbridge will assume the role of interim chief financial officer in addition to his current responsibilities.
However, Greiner will remain with the company to facilitate a smooth transition of duties up to the filing of the second fiscal quarter 10-Q, and has initiated a process to determine a permanent successor.
Additionally, the company is reaffirming its previously issued financial guidance for fiscal year 2020.
Airiver medical receives FDA approval for central airway stenosis trial
Talphera reaches enrollment milestone in NEPHRO CRRT pivotal trial
QT Imaging signs exclusive USD33m distribution deal with Gulf Medical in Saudi Arabia
Novocure submits FDA PMA for Tumor Treating Fields therapy in pancreatic cancer
Covalon Technologies secures DTC eligibility to expand US investor access
Navamedic ASA secures final approvals for Flexilev in OraFID across Nordic markets
Oncopeptides partners with SD Pharma to expand Pepaxti access in Spain
Aptar launches bio-based nasal spray pump with Haleon's Otrivin brand
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Alcon to acquire LumiThera and its FDA-authorised photobiomodulation device for dry AMD treatment
Predictmedix AI launches mobile diabetes screening platform in India
Navamedic's medical device OraFID approved as primary package for a pharmaceutical product
Speranza Therapeutics partners with Sunshine Labs for harm reduction solutions